Quest for the right Drug
אטרובנט ATROVENT ® (IPRATROPIUM BROMIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
שאיפה : INHALATION
צורת מינון:
משאף : INHALER
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Special Warning : אזהרת שימוש
4.4 Special warnings and precautions for use Hypersensitivity Immediate hypersensitivity reactions may occur following the use of Atrovent, as demonstrated, for example, by rare cases of rash, urticaria, angioedema, oropharyngeal oedema, bronchospasm and anaphylaxis. Paradoxical bronchospasm As with other inhaled medications, Atrovent may cause paradoxical bronchospasm, which may be life- threatening. If paradoxical bronchospasm occurs, Atrovent must be discontinued immediately and replaced with an alternative therapy. Special populations: Ocular complications Atrovent should be used with caution in patients with a predisposition for narrow-angle glaucoma. If the product accidentally comes into contact with the eyes during use, mild, reversible ocular comp- lications may occur. There is a risk of an acute glaucoma attack, particularly in patients with narrow- angle glaucoma; the characteristic symptoms are eye pain, blurred vision, visual halos or coloured images, red eyes and corneal oedema. If mydriasis and mild accommodation disordersoccur, treatment with miotic drops may be given. In the event of severe ocular complications, an ophthalmologist should also be consulted. As the inhaler is used in conjunction with a mouthpiece and is operated manually, the risk of the mist getting into the eyes is low. Effect on the kidneys and urinary tract In patients with micturition disorders (such as in prostatic hypertrophy or bladder neck obstruction), the benefit of treatment with ipratropium bromide must be carefully weighed against the potential risk of aggravating urinary retention. Gastrointestinal motility disorders Patients with cystic fibrosis are more likely to develop gastrointestinal motility disorders. Contains alcohol (less than 100 mg per dose).
Effects on Driving
שימוש לפי פנקס קופ''ח כללית 1994
Bronchospasm associated with asthma, chronic bronchitis and emphysema
תאריך הכללה מקורי בסל
01/01/1995
הגבלות
תרופה שאושרה לשימוש כללי בקופ'ח
מידע נוסף